Reprioritization – Talk Bio

Actionable Insights Powered by AI

Prime Medicine Partners with Bristol Myers Squibb in $3.5B Cell Therapy Deal, Narrows Pipeline Focus

7 months ago talkbio0Tagged BMS, Burning Mouth Syndrome, Cell Therapy, Edit, ex vivo, Gene Modification, Ifosfamide/Methotrexate/Procarbazine protocol, PASSIGE, pipeline, Prime Medicine, Reprioritization, squibb, strategic collaboration, Technology

Prime Medicine, Bristol Myers Squibb (BMS), Cell Therapy, Gene Editing, Prime Editing, PASSIGE Technology, Ex Vivo T-Cell Therapies, Pipeline Reprioritization, Strategic Collaboration

Genentech Closes Cancer Immunology Unit as Part of Broader R&D Restructuring

8 months ago talkbio0Tagged Cancer Immunology, Cancer Research, genentech, molecular oncology, R&D, Reprioritization, Roche (company)

Genentech, Cancer Immunology, R&D Reprioritization, Roche, Cancer Research, Molecular Oncology